濮阳东方医院男科技术值得放心濮阳东方看妇科病技术非常哇塞,濮阳东方医院做人流收费不贵,濮阳东方男科看病好不好,濮阳东方医院治疗早泄技术比较专业,濮阳东方医院价格合理,濮阳东方看男科病口碑好不好,濮阳东方看妇科评价高

With a majority of public school districts offering remote learning this fall, parents and teachers are ramping up online educational tools and resources for kids. Many are also focusing just as much on kids' mental health."It's going to be so much harder to build those relationships while you're on a virtual platform. What are we doing to start the year off with expectations of what students should do and how are they going to react with each other?" said Dr. Christina Conolly, a school psychologist in Maryland and a member of the National Association of School Psychologists. Dr. Conolly says with so many children missing that social interaction this fall, it's important for educators and parents to be intentional when it comes to keeping an eye on students' mental health."Anything we can do to help students engage with each other, bring a socialized setting that is supervised, is great," said Dr. Conolly. Before the COVID-19 pandemic, Dr. Conolly, like other parents, put major restrictions on screen time. Now, she says many of those limitations have gone out the window. Speaking about her own daughter, she says safe, online interaction is crucial to children's social development. "Right now, if she's on there spending a couple hours gaming with my neighbors because she can't go outside and play with my neighbors, well I'm like 'OK, it's helping her with her emotional health.' Because human beings need human interaction," said Dr. Conolly.Child suicide rates are up nationwide and calls into the National Suicide Prevention hotlines are skyrocketing, Dr. Conolly said. Many children who didn't have mental health struggles before the pandemic are finding themselves coping with them now and those who already had difficulties are getting worse. She has advice for parents who are concerned about their children getting depressed because of a lack of social interaction. "I would say a number of things. First, talk to the staff at your school. You can talk to the teacher, administration, psychologist or counselor in the building. If you're concerned, they can talk with your student," said Dr. Conolly.Teressa Ruspi is a parent of three and runs the LRJ Foundation, a mental health and wellness organization that partners with schools in Georgia, Virginia and Pennsylvania to teach kids about the importance of social emotional health. Ruspi is putting her own children's mental health at the top of her mind as her three head back to school virtually."I'm really trying to hone in and be really mindful of their emotions right now and what's triggering those emotions. How to balance those emotions, how to have those conversations with them, so they can feel comfortable talking to me about what's frustrating with them," said Ruspi. Ruspi says her kids are FaceTiming frequently with classmates and even doing occasional playdates with families who are taking similar precautions from COVID-19 as they are."Kids can get kind of complacent and used to their new surroundings so now that they have been removed and been remote and disconnected a lot, we want to make sure that they don't stay disconnected," Ruspi said.The good news, is that now that school is back in session, many parents will have access to free sessions with a school psychologist or counselor. An extra resource that could be an extra boost to keeping children happy and mentally healthy during virtual schooling. 3421

White House senior adviser Jared Kushner's family real estate group obtained business loans after Kushner met with the company heads in his official government capacity, The New York Times reported Wednesday.According to the Times, Kushner met with Joshua Harris, one of the founders of Apollo Global Management, on multiple occasions while advising the Trump administration on infrastructure policy, three people familiar with the meetings said.The topic of a job at the White House was also brought up, though never materialized. In November 2017, Apollo's real estate group lent Kushner Companies 4 million to refinance the mortgage of a Chicago skyscraper. The size of the loan, according to the Times, was triple the size of their average property loan.  775

When snow falls in a flurry and the weather is cold outside, escaping the elements becomes a top priority.With COVID-19 causing some warming shelters to stop operations this winter, however, the impacts could literally mean the difference between life and death.“We’re going to see a lot of people die to be perfectly honest,” said Robin Wood-Mason with The Delores Project, a homeless shelter in Denver, Colorado, that focuses on women and transgender folks.He says during a normal winter, this shelter can provide a warming space for dozens of people each day. But with a static population and a lack of social distancing, local health guidelines have forced them to shut their doors for warming shelters this season.“It’s heartbreaking,” Wood-Mason said of the warming shelter not being able to open this winter. “Here in Denver, we’ve got thousands more people experiencing than there are shelter beds available.”Across the country, other warming shelters are also being impacted by COVID concerns.“We’re just starting to inch into those winter months when we know things are going to get colder, things are going to look and feel a little different into our regions,” said Andrea Carlson with the American Red Cross.She says the days of having people packed in to one large room to get warm are gone. Now, they’re putting people into multiple separate spaces and following new COVID safety protocols.“Distanced between each other, masks are required, you do have some health checks when you come into the warming center,” Carlson said.As winter weather rolls in, and limited capacity issues mean more people are staying outside, The Delores Project believes more people will be exposed to harsh weather and the virus.“It means that we’re really going to see people get sick,” Wood-Mason said. “It’s going to put a new burden on the hospital system and our first responders.” 1887

With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them.Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines work by tricking the body into thinking there’s an infection so it makes antibodies and remembers how to do that if the real bug turns up.But it can take a month or two after vaccination or infection for the most effective antibodies to form. The experimental drugs shortcut that process by giving concentrated versions of specific ones that worked best against the coronavirus in lab and animal tests.“A vaccine takes time to work, to force the development of antibodies. But when you give an antibody, you get immediate protection,” said University of North Carolina virologist Dr. Myron Cohen. “If we can generate them in large concentrations, in big vats in an antibody factory ... we can kind of bypass the immune system.”These drugs are believed to last for a month or more and could give quick, temporary immunity to people at high risk of infection, such as health workers and housemates of someone with COVID-19. If they proved effective and if a vaccine doesn’t materialize or protect as hoped, the drugs might eventually be considered for wider use, perhaps for teachers or other groups.They’re also being tested as treatments, to help the immune system and prevent severe symptoms or death.“The hope there is to target people who are in the first week of their illness and that we can treat them with the antibody and prevent them from getting sick,” said Dr. Marshall Lyon, an infectious disease specialist helping to test one such drug at Emory University in Atlanta.Having such a tool “would be a really momentous thing in our fight against COVID,” Cohen said.Vaccines are seen as a key to controlling the virus, which has been confirmed to have infected more than 20 million people worldwide and killed more than 738,000. Several companies are racing to develop vaccines, but the results of the large final tests needed to evaluate them are months away.The antibody drugs are “very promising” and, in contrast, could be available “fairly soon,” said Dr. Janet Woodcock, a U.S. Food and Drug Administration official who is leading government efforts to speed COVID-19 therapies. Key studies are underway and some answers should come by early fall.One company, Eli Lilly, has already started manufacturing its antibody drug, betting that studies now underway will give positive results.“Our goal is to get something out as soon as possible” and to have hundreds of thousands of doses ready by fall, said Lilly’s chief scientific officer, Dr. Daniel Skovronsky.Another company that developed an antibody drug cocktail against Ebola — Regeneron Pharmaceuticals Inc. — now is testing one for coronavirus.“The success with our Ebola program gives us some confidence that we can potentially do this again,” said Christos Kyratsous, a Regeneron microbiologist who helped lead that work.Regeneron’s drug uses two antibodies to enhance chances the drug will work even if the virus evolves to evade action by one.Lilly is testing two different, single-antibody drugs — one with the Canadian company AbCellera and another with a Chinese company, Junshi Biosciences. In July, Junshi said no safety concerns emerged in 40 healthy people who tried it and that larger studies were getting underway.Others working on antibody drugs include Amgen and Adaptive Biotechnologies. The Singapore biotech company Tychan Pte Ltd. also is testing an antibody drug and has similar products in development for Zika virus and yellow fever.“I’m cautiously optimistic” about the drugs, said the nation’s top infectious diseases expert, Dr. Anthony Fauci. “I’m heartened by the experience that we had with Ebola,” where the drugs proved effective.What could go wrong?— The antibodies may not reach all of the places in the body where they need to act, such as deep in the lungs. All the antibody drugs are given through an IV and must make their way through the bloodstream to wherever they’re needed.— The virus might mutate to avoid the antibody — the reason Regeneron is testing a two-antibody combo that binds to the virus in different places to help prevent its escape.Skovronsky said Lilly stuck with one antibody because manufacturing capacity would essentially be cut in half to make two, and “you will have less doses available.” If a single antibody works, “we can treat twice as many people,” he said.— The antibodies might not last long enough. If they fade within a month, it’s still OK for treatment since COVID-19 illness usually resolves in that time. But for prevention, it may not be practical to give infusions more often than every month or two.A San Francisco company, Vir Biotechnology Inc., says it has engineered antibodies to last longer than they usually do to avoid this problem. GlaxoSmithKline has invested 0 million in Vir to test them.Giving a higher dose also may help. If half of antibodies disappear after a month, “if you give twice as much, you will have two months’ protection,” Lilly’s Skovronsky said.— The big fear: Antibodies may do the opposite of what’s hoped and actually enhance the virus’s ability to get into cells or stimulate the immune system in a way that makes people sicker. It’s a theoretical concern that hasn’t been seen in testing so far, but large, definitive experiments are needed to prove safety.“As best as we can tell, the antibodies are helpful,” Lyon said.___Marilynn Marchione can be followed on Twitter: @MMarchioneAP___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5919

When snow falls in a flurry and the weather is cold outside, escaping the elements becomes a top priority.With COVID-19 causing some warming shelters to stop operations this winter, however, the impacts could literally mean the difference between life and death.“We’re going to see a lot of people die to be perfectly honest,” said Robin Wood-Mason with The Delores Project, a homeless shelter in Denver, Colorado, that focuses on women and transgender folks.He says during a normal winter, this shelter can provide a warming space for dozens of people each day. But with a static population and a lack of social distancing, local health guidelines have forced them to shut their doors for warming shelters this season.“It’s heartbreaking,” Wood-Mason said of the warming shelter not being able to open this winter. “Here in Denver, we’ve got thousands more people experiencing than there are shelter beds available.”Across the country, other warming shelters are also being impacted by COVID concerns.“We’re just starting to inch into those winter months when we know things are going to get colder, things are going to look and feel a little different into our regions,” said Andrea Carlson with the American Red Cross.She says the days of having people packed in to one large room to get warm are gone. Now, they’re putting people into multiple separate spaces and following new COVID safety protocols.“Distanced between each other, masks are required, you do have some health checks when you come into the warming center,” Carlson said.As winter weather rolls in, and limited capacity issues mean more people are staying outside, The Delores Project believes more people will be exposed to harsh weather and the virus.“It means that we’re really going to see people get sick,” Wood-Mason said. “It’s going to put a new burden on the hospital system and our first responders.” 1887